Clik here to view.
Octapharma：罹患重症血友病A的既往未曾治疗患者(PUP)使用octanate®后，抑制因子的发生率降低
瑞士拉亨 (美国商业资讯) — Octapharma欣然宣布，国际著名医学期刊《Haemophilia》发表了一项在PUP中开展的符合临床试验规范(GCP)的试验的最终数据。该研究评估了octanate®在PUP重症血友病A中的免疫原性、有效性、安全性和耐受性。 PUPs重症血友病A发生抑制因子的风险最高。约35%发生抑制因子，因此造成有害的健康和经济后果。...
View ArticleClik here to view.
オクタファルマ：重度血友病Aの未治療患者がoctanate®を使用するとインヒビター発現率が低減
スイス・ラーヘン （ビジネスワイヤ） — オクタファルマは、未治療患者での適正臨床試験基準（GCP）準拠試験の最終データが、国際的に著名な医学誌「ヘモフィリア」に掲載されたと発表しました。試験では未治療の重度血友病A患者でoctanate®の免疫原性、有効性、安全性、忍容性を評価しました。...
View ArticleClik here to view.
Dr. Reddy’s Q3 and 9M FY18 Financial Results
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced its consolidated financial results for the third quarter and nine months ended December 31,...
View ArticleClik here to view.
Avita Medical Announces Five RECELL® Abstracts Accepted for Presentation at...
VALENCIA, Calif. & MELBOURNE, Australia Avita Medical (ASX – AVH, OTCQX: AVMXY) announced that five abstracts highlighting the compelling clinical data and health economic benefits of RECELL® in...
View ArticleClik here to view.
Micro Blood Science Inc.: Announcement of Developing the Next Generation...
TOKYO Micro Blood Science Inc. (hereinafter MBS), a Japanese blood testing device firm, today announces its plan to develop the next-generation blood test data management system which will securely...
View ArticleClik here to view.
株式会社マイクロブラッドサイエンス：高精度微量血液検査技術とブロックチェーンが融合する次世代ヘルスケアプラットフォーム構築のお知らせ
東京 （ビジネスワイヤ） – 株式会社マイクロブラッドサイエンス（本社：東京都千代田区、代表取締役岩澤 肇）は、微量血液検査システム”Lifee”で集積された血液検査データをより安全に管理すると同時に、蓄えられた検査データを様々な医療・健康関連サービスに幅広く活用するため、ブロックチェーンを用いた次世代ヘルスケアプラットフォームを開発することを決定いたしました。...
View ArticleClik here to view.
OMRON Boosts Net Earnings 52.4% to JPY46.7 Billion
KYOTO, Japan OMRON Corporation (TOKYO: 6645) today announced its consolidated operating results for the first nine months of fiscal 2017, ended December 31, 2018. Net sales for the term advanced...
View ArticleClik here to view.
Astellas Reports Financial Results for the First Nine Months of FY2017
TOKYO Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced the financial results for the first nine months of fiscal year 2017 ending March 31, 2018...
View ArticleAvita Medical Second Quarter 2018 Quarterly Cash Flow Report and Company Update
VALENCIA, Calif. & MELBOURNE, Australia Avita Medical (ASX: AVH, OTCQX: AVMXY), a regenerative medicine company with a technology platform positioned to address unmet medical needs in burns,...
View ArticleClik here to view.
Visioneering Technologies Achieves CE Mark for NaturalVue® Family of 1 Day...
ATLANTA Visioneering Technologies, Inc. (ASX: VTI), an innovative US-based medical device company dedicated to developing advanced products that improve vision, announced today receipt of the...
View ArticleClik here to view.
Takeda Reports 3rd Quarter FY2017 Results
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502): Underlying Revenue growth +6.7% led by Takeda’s Growth Drivers Underlying Revenue grew +6.7% year-to-date, with Takeda’s Growth...
View ArticleClik here to view.
武田薬品: 2017年度第3四半期（4-12月期）の連結業績について
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社 （東証：4502）： 実質的な売上収益は＋6.7％の増収、タケダの成長ドライバーが牽引 実質的な売上収益は対前年同期＋6.7％、タケダの成長ドライバー（消化器系疾患領域、オンコロジー（がん）領域、ニューロサイエンス（神経精神疾患）領域、新興国事業）は力強く成長し＋14.5％...
View ArticleClik here to view.
Puma Biotechnology and CANbridge Life Sciences Enter into Exclusive Licensing...
BEIJING CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, announced today that it has licensed the exclusive rights to...
View ArticleClik here to view.
武田药品工业株式会社公布2017财年第三季度业绩
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited)(TOKYO:4502)： 武田增长引擎带动基础营收增长+6.7% 基础营收增长+6.7%，武田的增长引擎（胃肠药、肿瘤药、神经科药物和新兴市场）基础营收保持强劲增长，增幅达到+14.5%。...
View ArticleClik here to view.
NTT DATA and Oracle Insurance to Offer End-to-End Solution for Government...
PLANO, Texas NTT DATA Services, a recognized leader in global technology services and a Platinum Cloud Standard member of Oracle PartnerNetwork (OPN), today announced a new end-to-end solution in...
View ArticleClik here to view.
自信显著提升：Look Good Feel Better全球调研显示其计划对接受癌症治疗的女性产生显著的积极影响
华盛顿 (美国商业资讯)–全球癌症支持计划Look Good Feel Better今天公布了2016/2017全球参与者调研结果。该结果显示其突破性计划对全球女性的自信和自我形象产生的影响。根据来自四大洲八个国家的调研结果，完成Look Good Feel Better计划的女性个人自信大幅上升78%。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Clik here to view.
International Olympic Committee and GE Healthcare Launch Analytics Tool to...
PYEONGCHANG, South Korea GE Healthcare today announced a new advanced analytics solution built for the Olympic Winter Games PyeongChang 2018 and to be used for the Olympic Games Tokyo 2020. Designed...
View ArticleClik here to view.
Agilent to Support Korea Doping Control Center
SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE:A) today announced it will collaborate with the Doping Control Center in Seoul, South Korea, to ensure that athletes from around the world are...
View ArticleClik here to view.
Masimo宣布，用于Rad-97™ 脉搏碳氧氧饱和度仪®的新生儿CCHD筛查应用Eve™获得CE标记
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布，用于Rad-97™脉搏碳氧氧饱和度仪®的新生儿危重型先天性心脏病(CCHD)筛查应用Eve™获得CE标记。Eve综合了Masimo SET®移动及低灌注下测量™脉搏氧饱和度仪的功能与管前至管后同步算法，旨在减少运算差错。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View Article